PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
14-Feb-2022 mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index mdgroup
11-Feb-2022 Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children Emmes
11-Feb-2022 Oxurion Announces Upcoming Presentation on THR-149 Phase 2 Clinical Trial (“KALAHARI”) at the Angiogenesis, Exudation, and Degeneration 2022 Conference Oxurion
09-Feb-2022 Book to attend the Parallel Trade conference before seats are filled SMi Group
09-Feb-2022 Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report Novotech
08-Feb-2022 Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation to expand its clinical investigations of CyPep-1 into rare neoplastic disease Cytovation
08-Feb-2022 AlzeCure is moving towards Phase IIa clinical trial with ACD440 based on guiding response from the FDA AlzeCure Pharma AB
08-Feb-2022 vasopharm GmbH Announces Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury vasopharm GmbH
08-Feb-2022 Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation to expand its clinical investigations of CyPep-1 into rare neoplastic disease Cytovation AS
08-Feb-2022 Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection and Speed Patient Enrollment in Clinical Trials Thermo Fisher Scientific
08-Feb-2022 Celltrion submits Investigational New Drug (IND) application to initiate a global Phase III clinical trial evaluating an inhaled COVID-19 antibody cocktail therapy Celltrion
08-Feb-2022 Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials Medidata
08-Feb-2022 HUTCHMED Initiates Phase Ib/II Study of HMPL-453 in Combination with Chemotherapy or Toripalimab for Advanced Solid Tumors in China HUTCHMED
04-Feb-2022 mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022 mdgroup
03-Feb-2022 mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022 mdgroup
03-Feb-2022 Pharming announces positive results of Phase II/III pivotal clinical study of leniolisib for the treatment of activated PI3K delta syndrome Pharming Group N.V.
03-Feb-2022 Only 14% of breast cancer trials reached optimal enrolment targets in 2021, despite being the most studied indication globally Phesi
02-Feb-2022 Reaxys to enhance chemistry patents with patent provenance for greater competitive intelligence insights Elsevier
01-Feb-2022 ZS and IgniteData Partner to Transform Patient Data Automation for Clinical Trials IgniteData
30-Jan-2022 Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference SMi Group